《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2014年 > 10期

 玉葵清对糖基化终产物诱导的人肾系膜细胞趋化因子表达的影响

来自:中国糖尿病杂志  编辑: 孙红 袁扬 周莉 余江毅 孙子林|点击数:|2014-10-21

糖尿病基础研究

  【摘要】目的 探讨玉葵清对糖基化终产物(AGEs)诱导的人肾系膜细胞(HRMC)趋化因子表达及其趋化效应的影响。 方法 糖基化牛血清白蛋白(AGE- BSA)和玉葵清干预HRMC。 结果 AGE- BSA组较BSA组HRMC趋化单核细胞数增加,MCP-1、Fractalkine中和抗体组HRMC趋化单核细胞数较AGE-BSA组减少;玉葵清组MCP-1、Fractalkine基因表达、上清中的蛋白含量和趋化单核细胞较BSA组降低(P<0.05)。结论 玉葵清减弱AGE- BSA诱导的HRMC趋化因子表达及其趋化效应,可能改善糖尿病肾病肾脏炎症反应。

  【关键词】糖基化终产物;MCP-1;fractalkine;玉葵清;糖尿病肾病

  【Abstract】Objective To further investigate the effect of YuKuiQing on the upregulation of monocyte chemoattractant protein-1 (MCP-1) and fractalkine (FKN) induced by AGEs. Methods Human renal mesangial cells (HRMC) was cultured in the presence of AGE-BSA with or without anti-MCP-1 and anti-FKN antibody or YuKuiQing. The capacity of MCP-1 and FKN to induce monocytes transmigration was detected with a Transwell system. The MCP-1 and FKN mRNA and protain in HRMC were analyzed by RT-PCR and ELISA. Results 1.The number of monocytes migrating to HRMC was higher in AGE-BSA group than in control and anti-MCP-1 or anti-FKN antibody-blocking groups(P<0.01). 2. The number of monocytes migrating to HRMC was lower of YuKuiQing than in control and AGE-BSA (P<0.01)group. 3. Expression of MCP-1 and FKN mRNA significantly lower in YuKuiQing group than in control group (P<0.01) and AGE-BSA(P<0.05) group. 4. In YuKuiQing group, the contents of MCP-1 and FKN in supernatant were significantly decreased compared to control and AGE-BSA groups (P<0.01). Conclusions 1. AGE-BSA enhances the capacity of MCP-1 and FKN to induce monocytes transmigration to HRMC, which are inhibited by anti-MCP-1 and anti-FKN antibody partially. These findings suggest that MCP-1 and FKN might mediate the role of AGEs in the development of diabetic nephropathy. 2. YuKuiQing can markedly reduce the upregulation of MCP-1 and FKN induced by AGE-BSA, and attenuate the capacity of MCP-1 and FKN to induce monocytes transmigration to HRMC. These results indicate that YuKuiQing might play its role of renal protection.

  【Key words】 Advanced glycation end products; MCP-1;Fractalkine; YuKuiQing; Diabetic nephropathy

上一篇: 不同干预方式对新诊断2型糖尿病患者胰岛功能和血清PEDF的影响 下一篇:二肽基肽酶4抑制剂沙格列汀改善过氧化氢诱导损伤的血管内皮细胞一氧化氮和内皮素1的分泌异常